Literature DB >> 15071490

Investigation of cavernosal smooth muscle dysfunction in low flow priapism using an in vitro model.

A Muneer1, S Cellek, A Dogan, P D Kell, D J Ralph, S Minhas.   

Abstract

The effects of hypoxia (pO2: 50 mmHg), acidosis (pH: 6.9) or glucopenia (absence of glucose) in vitro on the tone of the rabbit corpus cavernosum were investigated. The recovery of smooth muscle contractility following exposure to these conditions was also assessed. Hypoxia, acidosis or glucopenia alone or in combination showed a sustained reduction in the tone. Reperfusion of tissue strips showed complete recovery of smooth muscle tone for all conditions except when hypoxia and glucopenia were combined or when hypoxia, glucopenia and acidosis were used in combination. Incomplete recovery of tone was associated with a significant reduction in tissue ATP concentrations and an increase in the number of TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick-end labelling)-positive nuclei. This indicates that following reversal of hypoxia, acidosis and glucopenia, failure of conventional alpha-adrenergic agonists to produce tumescence in low flow priapism is associated with irreversible smooth muscle cell dysfunction, which is linked to ATP reduction and smooth muscle cell death.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15071490     DOI: 10.1038/sj.ijir.3901231

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  14 in total

Review 1.  Stuttering priapism: insights into pathogenesis and management.

Authors:  Belinda F Morrison; Arthur L Burnett
Journal:  Curr Urol Rep       Date:  2012-08       Impact factor: 3.092

Review 2.  Recent advances in the medical and surgical treatment of priapism.

Authors:  Adam Shrewsberry; Aaron Weiss; Chad W M Ritenour
Journal:  Curr Urol Rep       Date:  2010-11       Impact factor: 3.092

Review 3.  Microvascular dysfunction and efficacy of PDE5 inhibitors in BPH-LUTS.

Authors:  Selim Cellek; Norman E Cameron; Mary A Cotter; Christopher H Fry; Dapo Ilo
Journal:  Nat Rev Urol       Date:  2014-03-11       Impact factor: 14.432

4.  Diagnostic and therapeutic options for the management of ischemic and nonischemic priapism.

Authors:  Jeffrey Bassett; Jacob Rajfer
Journal:  Rev Urol       Date:  2010

Review 5.  Prophylactic phenylephrine for iatrogenic priapism: a pilot study with Peyronie's patients.

Authors:  Pengbo Jiang; Athena Christakos; Mina Fam; Hossein Sadeghi-Nejad
Journal:  Korean J Urol       Date:  2014-10-10

6.  Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling.

Authors:  Tiejuan Mi; Shahrzad Abbasi; Hong Zhang; Karen Uray; Janci L Chunn; Ling Wei Xia; Jose G Molina; Norman W Weisbrodt; Rodney E Kellems; Michael R Blackburn; Yang Xia
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

7.  Adenosine deaminase enzyme therapy prevents and reverses the heightened cavernosal relaxation in priapism.

Authors:  Jiaming Wen; Xianzhen Jiang; Yingbo Dai; Yujin Zhang; Yuxin Tang; Hong Sun; Tiejuan Mi; Rodney E Kellems; Michael R Blackburn; Yang Xia
Journal:  J Sex Med       Date:  2010-09       Impact factor: 3.802

Review 8.  Medical and surgical management of priapism.

Authors:  J Cherian; A R Rao; A Thwaini; F Kapasi; I S Shergill; R Samman
Journal:  Postgrad Med J       Date:  2006-02       Impact factor: 2.401

Review 9.  Priapism: new concepts in the pathophysiology and new treatment strategies.

Authors:  Trinity J Bivalacqua; Arthur L Burnett
Journal:  Curr Urol Rep       Date:  2006-11       Impact factor: 2.862

10.  Risk Factors for Surgical Shunting in a Large Cohort With Ischemic Priapism.

Authors:  Hanson Zhao; Kai Dallas; John Masterson; Eric Lo; Justin Houman; Carl Berdahl; Joshua Pevnick; Jennifer T Anger
Journal:  J Sex Med       Date:  2020-11-15       Impact factor: 3.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.